drugset / Trial / NCT01001234

A Study to Evaluate the Efficacy and Tolerability of Rizatriptan for Treatment of Acute Migraine in Children and Adolescents (MK-0462-082 AM7)

NCT01001234

Phase 3 Completed 1382 enrolled Organon and Co
RandomizedParallel-groupTriple-blindTreatment

Summary

This Clinical Trial evaluates the Safety and Efficacy of Rizatriptan for the Acute Treatment of Migraine in Children and Adolescents.

Timeline

Start
2009-11-30
Primary completion
2011-04-21
Completion
2011-04-21

Drugs

EvaluationDrugModalityDoseRoute
Subject rizatriptan Unknown 5 mg Oral
Subject rizatriptan Unknown 10 mg Oral

Indications